Ophthalmology · Los Angeles, CA
NPI
1902916711
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
9
Medicare group memberships
Hospitals
2
Hospital affiliations
7447 N Figueroa St, Suite 200
Los Angeles, CA, 90041
Phone (323) 257-3937
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
22,217 services
Medicare patients, 2024
955
Average age 72
Drug cost, 2024
$2.7M
11,014 prescriptions
Company payments, 2025
$940
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khaled A Tawansy was code J2777 (injection, faricimab-svoa, 0.1 mg), 10,504 times for 122 patients. In total Khaled A Tawansy billed 22,217 services in 91 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 10,504 | 122 | $27.42 | $288K |
| J0178 Injection, aflibercept, 1 mg | Office | 2,733 | 421 | $651.62 | $1.8M |
| 92134 Computerized Ophthalmic Imaging | Office | 2,126 | 795 | $31.65 | $67K |
| 99214 Office E&M - Established | Office | 1,733 | 725 | $96.58 | $167K |
| 67028 Intravitreal Injection | Office | 1,484 | 566 | $115.31 | $171K |
| 92201 Ophthalmological E&M | Office | 1,125 | 586 | $19.16 | $22K |
| 99213 Office E&M - Established | Office | 402 | 228 | $67.83 | $27K |
| J9035 Injection, bevacizumab, 10 mg | Office | 368 | 170 | $58.00 | $21K |
| J7999 Compounded drug, not otherwise classified | Office | 254 | 156 | $71.31 | $18K |
| 76512 Ultrasound - Nonspecific | Office | 180 | 80 | $28.17 | $5,071 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 174 | 59 | $0.77 | $135 |
| 66984 Cataract Surgery | Facility | 169 | 125 | $293.38 | $50K |
| 99204 Office E&M - New | Office | 145 | 145 | $120.69 | $18K |
| 67515 Eye | Office | 69 | 60 | $29.54 | $2,039 |
| 67039 Vitrectomy - Mechanical | Facility | 52 | 46 | $698.77 | $36K |
By year: 2022 $3.6M for 9,171 services; 2023 $2.9M for 7,934 services; 2024 $2.9M for 22,217 services.
Medicare prescription drug claims, 2024
In 2024, the drug Khaled A Tawansy prescribed most often to Medicare patients was Tobramycin-Dexamethasone (Tobramycin/Dexamethasone), with 1,181 prescriptions and refills. In total Khaled A Tawansy wrote 11,014 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 1,181 | 1,434 | 485 | $53K |
| Prednisolone Acetate Generic | 1,097 | 1,487 | 413 | $49K |
| Erythromycin Erythromycin Base | 995 | 1,019 | 400 | $9,899 |
| Xiidra Lifitegrast | 961 | 1,107 | 328 | $741K |
| Fluorometholone Generic | 550 | 691 | 225 | $45K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 455 | 480 | 211 | $4,638 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 443 | 557 | 138 | $66K |
| Combigan Brimonidine Tartrate/Timolol | 418 | 521 | 111 | $133K |
| Ketorolac Tromethamine Generic | 392 | 493 | 205 | $7,083 |
| Atropine Sulfate Generic | 392 | 668 | 212 | $17K |
| Brimonidine Tartrate Generic | 389 | 603 | 99 | $12K |
| Omega-3 Acid Ethyl Esters Generic | 376 | 638 | 135 | $19K |
| Cyclosporine Generic | 343 | 425 | 122 | $111K |
| Timolol Maleate Generic | 304 | 534 | 92 | $3,391 |
| Eysuvis Loteprednol Etabonate | 261 | 325 | 113 | $134K |
Brand drugs: - claims; generic drugs: 5,669 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khaled A Tawansy $940 ($940 in general payments such as food, travel and fees) from 12 companies. The largest payer was Bausch & Lomb Americas Inc. with $244.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 10 | $244 |
| Abbvie Inc. ABBV | 9 | $157 |
| Mallinckrodt Hospital Products Inc. | 4 | $106 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $106 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $73.78 |
| Alcon Vision LLC ALC | 2 | $61.51 |
| Dompe US, Inc. | 2 | $52.03 |
| Oyster Point Pharma, Inc. | 2 | $46.76 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $31.64 |
| Genentech USA, Inc. ROG.SW | 1 | $29.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.